Talking about recommended age or fewer doses: what motivates HPV vaccination timeliness?
- PMID: 33961539
- PMCID: PMC8381803
- DOI: 10.1080/21645515.2021.1912550
Talking about recommended age or fewer doses: what motivates HPV vaccination timeliness?
Abstract
HPV vaccination is recommended for U.S. adolescents at ages 11-12 and requires two versus three doses if the series is started before age 15. We evaluated how talking about recommended age or fewer doses motivates on-time HPV vaccination. Our national, online experiment randomized 1,263 parents of adolescents to view one of three messages about HPV vaccination recommendations or no message. Messages framed guidelines as recommending: vaccination at age 11-12; fewer doses for those who start vaccination at age 11-12; or, fewer doses for those who start vaccination before age 15. We then assessed parents' preferred age for HPV vaccination, categorizing preferences of ≤12 years as on-time. Parents who viewed "at age 11-12" versus no message more often preferred on-time HPV vaccination (63% vs. 43%, p < .05) and did not differ from those viewing "fewer doses at age 11-12" (63% vs. 64%, p > .05). Parents who viewed "fewer doses before age 15" less often preferred on-time HPV vaccination (39%, p < .05). Recommending HPV vaccination at age 11-12 encouraged on-time vaccination, while offering fewer doses had little impact. Providers should avoid framing HPV vaccination guidelines in reference to age 15 because doing so may discourage on-time vaccination by introducing confusion about the recommended age.
Keywords: adolescent health; human papillomavirus infections/prevention & control; human papillomavirus vaccine; patient-provider communication.
Figures
References
-
- Arbyn M, Bryant A, Beutels P, Martin-Hirsch PP, Paraskevaidis E, Van Hoof E, Steben M, Qiao Y, Zhao F-H, Schneider A. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database System Rev. 2011;2011(4):4. doi: 10.1002/14651858.CD009069. - DOI - PMC - PubMed
-
- Meites E. Use of a 2-dose schedule for human papillomavirus vaccination—updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2016; 65. - PubMed
-
- Iversen OE, Miranda MJ, Ulied A, Soerdal T, Lazarus E, Chokephaibulkit K, Block SL, Skrivanek A, Nur Azurah AG, Fong SM. Immunogenicity of the 9-Valent HPV vaccine using 2-dose regimens in girls and boys vs a 3-dose regimen in women. Jama. 2016;316(22):2411–21. doi: 10.1001/jama.2016.17615. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources